Evidence map›Paper›PMID 20206282›Full record

ArticleFungal genetics and biology : FG & B2010

Role of the homologous recombination genes RAD51 and RAD59 in the resistance of Candida albicans to UV light, radiomimetic and anti-tumor compounds and oxidizing agents.

Fátima García-Prieto, Jonathan Gómez-Raja, Encarnación Andaluz, Richard Calderone, Germán Larriba

Abstract read
In one paragraph

Article in Fungal genetics and biology : FG & B, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 30 citations in OpenAlex.

  1. Transcriptional Profiling of theInternational journal of molecular sciences · 2022
    Article
  2. DNA damage checkpoint and repair: From the budding yeastComputational and structural biotechnology journal · 2021
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Fátima García-PrietoDepartamento de Microbiología, Facultad de Ciencias, Universidad de Extremadura, 06071 Badajoz, Spain.
Jonathan Gómez-Raja
Encarnación Andaluz
Richard Calderone
Germán Larriba
Universidad de Extremadura · ESGeorgetown University · US

Funding

DNA Repair Mechanisms in Candida albicansR01AI051949 · NIAID · GEORGETOWN UNIVERSITY · PI CALDERONE, RICHARD ARTHUR · 2003 to 2006
$1.1M
NIAID NIH HHS 1 R01 AI51949NIAID NIH HHS R01 AI051949
6 · The paper itself

Abstract

We have cloned and characterized the RAD51 and RAD59 orthologs of the pathogenic fungus Candida albicans. CaRad51 exhibited more than 50% identity with several other eukaryotes and the conserved the catalytic domain of a bacterial RecA. As compared to the parental strain, null strains of rad51 exhibited a filamentous morphology, had a decreased grow rate and exhibited a moderate sensitivity to UV light, oxidizing agents, and compounds that cause double-strand breaks (DSB), indicating a role in DNA repair. By comparison, the rad52 null had a higher percentage of filaments, a more severe growth defect and a greater sensitivity to DNA-damaging compounds. Null strains of rad59 showed a UV-sensitive phenotype but behaved similarly to the parental strain in the rest of the assays. As compared to Saccharomyces cerevisiae, C. albicans was much more resistant to bleomycin and the same was true for their respective homologous recombination (HR) mutants. These results indicate that, as described in S. cerevisiae, RAD52 plays a more prominent role than RAD51 in the repair of DSBs in C. albicans and suggest the existence of at least two Rad52-dependent HR pathways, one dependent and one independent of Rad51.

Indexed as

Drug Resistance, FungalRecombination, GeneticAntineoplastic AgentsCandida albicansDNA Breaks, Double-StrandedDNA DamageDNA RepairFungal ProteinsOxidantsRad51 RecombinaseRadiation ToleranceUltraviolet RaysAntineoplastic AgentsFungal ProteinsOxidantsRad51 Recombinase

Identifiers

PMID20206282
PMCPMC2852118
OpenAlexW2151135651

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.